Abstract
A model was developed that characterized the maturation and growth of the renal function parameters (RFPs) glomerular filtration rate (GF), active tubular secretion (AS), and renal plasma flow (QR). Published RFP values were obtained from 63 healthy children between the ages of 2 days and 12 years. Maturation over time was assumed to be exponential from an immature (RFPim) to a mature (RFPma) level; for growth, RFPim and RFPma were assumed to follow the allometric equation: RFP(age, W)=aWbe−kmat*age+cWb(1−e−kmat*age), where W is body weight, kmat is the maturation rate constant, b is the body weight exponent, and a and c are RFPim and RFPma at unit W. The model-based equation was fitted to the age-W, RFP values by a nonlinear least-squares method. For GF, the maturation half-life was 7.9 months (90% maturation, 26 months), the body weight exponent was 0.662, and the ratio c/a (which reflected the magnitude of the maturation influence) was 3.1. For AS and QR, the maturation half-lives were about 3.8 months and the ratio c/a was about 1.8. For renally eliminated drugs, the model can be used to estimate dosing regimens that are based on the adult dosing regimen and the age and weight of the child.
KeyWords: Renal Function
References
- 1.Rowland M, Tozer T. Clinical Pharmacokinetics, Concepts and Applications. 3rd ed. Baltimore: Williams and Wilkins; 1995. pp. 83–105. [Google Scholar]
- 2.Benet L, Oie S, Schwartz J. Appendix II: Design and optimization of dosage regimens; pharmacokinetic data. In: Hardman J, Limbird L, Molinoff P, Ruddon R, Gilman A, editors. Goodman And Gilmans The Pharmacological Basis Of Therapeutics. 9th ed. New York: McGraw-Hill; 1996. pp. 1707–1792. [Google Scholar]
- 3.Crom WR. Pharmacokinetics in the child. Environ Health Perspect. 1994;102:111–117. doi: 10.1289/ehp.94102s11111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Rowland M, Tozer T. Clinical Pharmacokinetics, Concepts and Applications. 3rd ed. Baltimore: Williams and Wilkins; 1995. pp. 230–247. [Google Scholar]
- 5.Lam YWF, Banerji S, Hatfield C, Talbert RL. Principles of drug administration in renal insufficiency. Clin Pharmacokinet. 1997;32:30–57. doi: 10.2165/00003088-199732010-00002. [DOI] [PubMed] [Google Scholar]
- 6.Hayton W, Kneer J, Groot R, Stoeckel K. Influence of maturation and growth on cefetamet pivoxil pharmacokinetics: rational dosing for infants. Antimicrob Agents Chemother. 1996;40:567–574. doi: 10.1128/aac.40.3.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Rubin M, Bruck E, Rapoport M. Maturation of renal function in childhood: clearance studies. J Clin Invest. 1949;28:1144–1162. doi: 10.1172/JCI102149. [DOI] [PubMed] [Google Scholar]
- 8.Schmidt-Nielsen K. Scaling. Why is Animal Size So important? Cambridge: Cambridge University Press; 1984. pp. 14–32. [Google Scholar]
- 9.Hallynck T, Soep H, Thomis J, Boelaert J, Daneels R, Dettli L. Should clearance be normalised to body surface or to lean body mass? Br J Pharmacol. 1981;11:523–526. doi: 10.1111/j.1365-2125.1981.tb01163.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Heilbron DC, Holliday MA, Al-Dahwi A, Kogan BA. Expressing glomerular filtration rate in children. Pediatr Nephrol. 1991;5:5–11. doi: 10.1007/BF00852829. [DOI] [PubMed] [Google Scholar]
- 11.Anderson B, McKee A, Holford N. Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients. Clin Pharmacokinet. 1997;33:313–327. doi: 10.2165/00003088-199733050-00001. [DOI] [PubMed] [Google Scholar]
- 12.Diem K, Lentner C, editors. Scientific Tables. Basie, Switzerland: Ciba-Geigy Ltd.; 1970. pp. 693–705. [Google Scholar]
- 13.Kauffman RE. Status of drug approval processes and regulation of medications for children. Curr Opin Pediatr. 1995;7:195–198. doi: 10.1097/00008480-199504000-00014. [DOI] [PubMed] [Google Scholar]
- 14.Anon. Pediatric rule. AAPS News. 1999; February:4–5.
- 15.Rowland M, Tozer T. Clinical Pharmacokinetics, Concepts and Applications. 3rd ed. Baltimore: Williams and Wilkins; 1995. pp. 254–255. [Google Scholar]